“
“The present study was designed to investigate diabetes
induced germ cell apoptosis in testis and its protection by treatment with hexane fraction of hydro-methanolic extract of root of Musa paradisiaca and leaf of Coccinia indica in composite manner. Testicular oxidative stress injury was reflected by diminution in the activities of antioxidant enzymes such as catalase, peroxidase, superoxide dismutase and glutathione-s-transferase along with elevation in levels of conjugated diene and thiobarbituric acid reactive substances in diabetic condition. Serum testosterone and insulin levels were decreased in association with elevation in apoptosis of pancreatic islet cells in diabetic rats. Giant cells number along with elevation in the number of apoptotic cells were noted in seminiferous tubules in diabetic model animals. Significant improvements in the levels of
AZD8931 Protein Tyrosine Kinase inhibitor Integrase inhibitor blood glucose, serum insulin and testosterone and testicular oxidative stress parameters were noted versus control after treatment of said fraction at a dose of 2 mg (1 : 3)/0.2 nil olive oil per 100 g body weight per day for 45 days to diabetic rats. Numbers of giant cells in seminiferous tubules, apoptotic germ cells and apoptotic pancreatic islet cells were decreased significantly in fraction treated diabetic group versus control. From UV-spectroscopic and TLC studies in connection with phytochemical screening of the said fraction, phenol, flavonoid and alkaloid types of compound were found. From these results it may be concluded that the active ingredient(s) present in hexane fraction of root of Musa paradisiaca and leaf of Coccinia indica have the potential to correct diabetes-induced testicular germ cell apoptosis.”
“OBJECTIVE: Anticoagulation is a challenge for the prophylaxis of thromboembolic events in elderly patients with chronic atrial fibrillation. Stable anticoagulation is defined as the time within > 70% of the therapeutic range. However, the dosage required to achieve
stable anticoagulation remains unknown. The aim of this study was to analyze the warfarin HM781-36B chemical structure dose necessary for the maintenance of stable oral anticoagulation therapy in elderly patients.
METHODS: We analyzed 112 consecutive outpatients with atrial fibrillation who were >= 65 years of age, had received anticoagulation therapy with warfarin for more than 1 year and had a stable international normalized ratio between 2.0 and 3.0 for >= 6 months. The international normalized ratio was measured in the central laboratory using the traditional method.
RESULTS: The patients were stratified according to the following age groups:,75 or >= 75 years and <80 or >= 80 years. The mean daily doses of warfarin were similar for patients, <75 or >= 75 years (3.34 +/- 1.71 versus 3.26 +/- 1.27 mg/day, p = 0.